CURIE-CANCER, the body responsible for developing Institut Curie’s industry partnership activities, and is renewing its partnership with DNA Therapeutics.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
